focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

  • This share is currently suspended. It was suspended at a price of 5.375

Share Price Information for Iconic Labs (ICON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.375
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.375
ICON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Infotagion Readers Now Over 2 million

21 Apr 2020 14:00

RNS Number : 3792K
Iconic Labs PLC
21 April 2020
 

 

 

21st April 2020

 

 

Iconic Labs Plc ("Iconic Labs" or the "Company")

Infotagion Readers Now Over 2 million as they announce major partnership with M&C Saatchi and launch of new podcast

 

• Announcement of new partnership with award winning advertising agency M&C Saatchi

• Infotagion has now reached over 2 million people through more than 87 pieces of news

• Launch of weekly podcast featuring Damian Collins MP, Iconic Labs and key media influencers

• In negotiation with several world leading Universities about using platform and data

Iconic Labs Plc (LSE:ICON) (the "Company"), a multi-divisional new media and technology business, announces a new partnership with the award winning advertising agency, M&C Saatchi after the successful launch of Infotagion which has now reached over 2 million readers - doubling the reach from launch. 

Infotagion were approached by M&C Saatchi to work together on a pro bono (unpaid) basis. M&C Saatchi is launching, through Infotagion, 'Find the Truth. Isolate the Lies', a mythbusting campaign that will expose the most dangerous lies circulating about Covid-19 and reveal new ones as they arise. The free service is managed by the founders of Iconic Labs who are leading the direction, distribution and amplification of the campaign across traditional and social media. The launch is supported entirely through earned media (unpaid), including News UK, across titles such as The Sun, The Times and Talk Radio. The work will launch first in the United Kingdom followed swiftly by the United States and Canada.

Partnership between the three companies comes at a time when most major new sources are reporting on the issue. In addition, the United Nations has issued an open brief to the creative community asking for support in tackling misinformation surrounding COVID-19, the results of that contest will be announced at the end of April.

Infotagion has also launched a weekly podcast which will feature Damian Collins MP, former Chair of the Parliamentary Committee on Culture, Media and Sport and a member of the Iconic Labs team along with key media influencer guests. The first episode is out now and available on iTunes and Spotify and features John Quinlan, Damian Collins and Baroness Kidron.

Since the media launch of Infotagion there has been more than 87 pieces of individual news covered by the UK's major news outlets including the BBC, ITV, Daily Mail, radio and local and specialist news sites. 

The full list of media coverage surrounding Infotagion can be found here: https://www.iconiclabs.co.uk/infotagion-the-battle-against-disinformation/

In addition to this the group of supporters within governments and organisations around the world continues to grow and the full list is updated on the Infotagion website.

The company has been approached by a number of organisations including world leading Universities about using the Infotagion platform and data. The company looks forward to updating the market with the progress of these plans.

John Quinlan, Chief Executive Officer of Iconic Labs, said: ""We have made a very strong start with Infotagion. To receive such a response in such a short period of time just goes to show how important this service is to the public. The support has been unprecedented and the platform is growing day by day. The new podcast is the next stage of development and hopefully there will be much more to come. We plan to keep growing this platform and increasing the awareness of what Infotagion and Iconic Labs can achieve."

Infotagion

The Company announced a few weeks ago that, in partnership with Damian Collins MP, former Chair of the Parliamentary Committee on Culture, Media and Sport, it had established a service to counter the dissemination of incorrect information, in particular through social media, that relates to the Covid-19 pandemic and its related economic and social effects.

The core of the service is a website (www.infotagion.co.uk ) on which users post screenshots of information which they have received from social media or elsewhere. The submitted information is checked by a team organised by Mr Collins, which includes experts from, inter alia, the WHO and Parliament.

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

**ENDS**

 

For further information, please visit the Company's website www.iconiclabs.co.uk or contact:

 

Damon Heath

Shard Capital Partners LLP

Tel: +44 (0) 20 7186 9950

 

Iconic Labs

ir@iconiclabs.co.uk

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKKDBPBBKDBQB
Date   Source Headline
1st May 20187:02 amRNSAnnual Accounts and Fundraising Update
26th Mar 20187:00 amRNSLandmark deal to launch CellPlan insurance in Asia
19th Mar 20187:00 amRNSGranted Innovate UK KTP for Stem Cell Research
27th Feb 20187:00 amRNSLicence Award from the Human Tissue Authority
19th Feb 20187:00 amRNSBoard Changes and Launch of Wideacademy Platform
21st Dec 20177:00 amRNSCorporate Update
2nd Nov 20177:00 amRNSRevenue generation with White Apex agreement
12th Oct 20177:00 amRNSCellPlan expansion, e-commerce platform launch UK
11th Oct 20177:00 amRNSPartner Secured to Expand into MENA & Asia-Pacific
29th Sep 20177:00 amRNSInterim Results
25th Sep 20177:00 amRNSWideacademy Update, Presenting at Investor Event
15th Aug 20177:00 amRNSRaises £750,000 to support Company's divisions
31st Jul 20177:00 amRNSResearch Licence Granted from HTA
24th Jul 20177:00 amRNSNew product to target the dental market
21st Jul 20177:00 amRNSCellPlan launches E-Commerce Platform in the UK
12th Jul 20177:00 amRNSCorporate Charity Commitment
4th Jul 20177:00 amRNSAgreement to Roll Out CellPlan in Brazil
3rd Jul 20177:00 amRNSInvestor Evening and CFO Now Employed Full-time
27th Jun 20177:00 amRNSRevenue with launch of CellPlan
22nd Jun 20173:30 pmRNSResults of AGM
22nd Jun 20177:00 amRNSAGM Statement and Notice of Investor Evening
12th Jun 20177:00 amRNSWideAcademy Strategic Update
6th Jun 20177:00 amRNSLaunch of CellPlan set to generate maiden revenues
2nd Jun 20177:00 amRNSWideCells Named 21st in Global DISRUPT 100 List
23rd May 20177:00 amRNSAttendance at British Dental Conference
15th May 20177:00 amRNSAttendance at Brazilian Conference
4th May 20172:15 pmRNSHolding(s) in Company
2nd May 20177:40 amRNSPosting of Report and Accounts and Notice of AGM
12th Apr 20171:00 pmRNSPlacing
30th Mar 20177:00 amRNSPreliminary Results
16th Feb 20177:00 amRNSBoard Appointment
31st Jan 20177:00 amRNSDirector Purchases and Grant of Options
30th Jan 20174:40 pmRNSSecond Price Monitoring Extn
30th Jan 20174:35 pmRNSPrice Monitoring Extension
26th Jan 201710:30 amRNSGrant of Options
24th Jan 20177:00 amRNSExtends CellPlan Roll Out & New Product Launch
9th Jan 20177:00 amRNSDefinitive Agreement with BioVault for CellPlan
30th Nov 20167:00 amRNSNew Revenue Stream: Stem Cell Research, Manchester
7th Nov 20167:00 amRNSLOI with 1st Cord Blood Bank to Roll Out CellPlan
24th Oct 20167:00 amRNSCorporate Update
10th Oct 20167:00 amRNSUpdate on CellPlan
27th Sep 20167:00 amRNSPartners with University of Westminster
5th Sep 20167:00 amRNSLaunches WideCells Brasil
12th Aug 20167:00 amRNSHoldings In Company
5th Aug 20167:00 amRNSUpdate on Manchester Facility and Appointments
27th Jul 20168:00 amRNSPlacing & First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.